A Chicoye

657 total citations
17 papers, 526 citations indexed

About

A Chicoye is a scholar working on Endocrinology, Diabetes and Metabolism, Economics and Econometrics and Health. According to data from OpenAlex, A Chicoye has authored 17 papers receiving a total of 526 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Endocrinology, Diabetes and Metabolism, 4 papers in Economics and Econometrics and 3 papers in Health. Recurrent topics in A Chicoye's work include Health Systems, Economic Evaluations, Quality of Life (4 papers), Medication Adherence and Compliance (3 papers) and Pharmaceutical Practices and Patient Outcomes (3 papers). A Chicoye is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (4 papers), Medication Adherence and Compliance (3 papers) and Pharmaceutical Practices and Patient Outcomes (3 papers). A Chicoye collaborates with scholars based in France, Spain and Netherlands. A Chicoye's co-authors include A Richard, Jean Bousquet, F.B. Michel, John E. Ware, Jalel Knani, H. Dhivert, Julie Chevalier, R. Fadel, Sylvie Tison and H Massiou and has published in prestigious journals such as PLoS ONE, American Journal of Respiratory and Critical Care Medicine and Vaccine.

In The Last Decade

A Chicoye

14 papers receiving 493 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A Chicoye France 7 254 148 117 91 89 17 526
Peg Strub United States 9 501 2.0× 358 2.4× 40 0.3× 41 0.5× 267 3.0× 10 879
K. Annunziata United States 10 361 1.4× 249 1.7× 39 0.3× 26 0.3× 65 0.7× 29 679
F. S. Wamboldt United States 9 328 1.3× 348 2.4× 19 0.2× 39 0.4× 133 1.5× 12 664
Tamara J. Musumeci‐Szabó United States 5 218 0.9× 157 1.1× 11 0.1× 63 0.7× 129 1.4× 6 483
Caroline Stridsman Sweden 21 771 3.0× 778 5.3× 116 1.0× 40 0.4× 108 1.2× 84 1.2k
Dennis Thomas Australia 12 326 1.3× 155 1.0× 39 0.3× 11 0.1× 82 0.9× 42 574
Melina Rincon United States 9 154 0.6× 76 0.5× 9 0.1× 52 0.6× 311 3.5× 9 595
Reinier P. Akkermans Netherlands 16 267 1.1× 356 2.4× 14 0.1× 43 0.5× 147 1.7× 38 712
K Trakas Canada 9 64 0.3× 31 0.2× 14 0.1× 92 1.0× 98 1.1× 15 501
Lisette van den Bemt Netherlands 13 290 1.1× 336 2.3× 94 0.8× 8 0.1× 90 1.0× 35 538

Countries citing papers authored by A Chicoye

Since Specialization
Citations

This map shows the geographic impact of A Chicoye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Chicoye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Chicoye more than expected).

Fields of papers citing papers by A Chicoye

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Chicoye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Chicoye. The network helps show where A Chicoye may publish in the future.

Co-authorship network of co-authors of A Chicoye

This figure shows the co-authorship network connecting the top 25 collaborators of A Chicoye. A scholar is included among the top collaborators of A Chicoye based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Chicoye. A Chicoye is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Kövesdy, Csaba P., Natalie Ebert, David Vizcaya, et al.. (2025). Change in Urine Albumin-Creatinine Ratio and Occurrence of Hyperkalemia in Patients Initiating Finerenone in the USA: A Cohort Study from the FOUNTAIN Platform. ˜The œNephron journals/Nephron journals. 149(7). 371–383.
2.
3.
Chicoye, A, Pascal Crépey, Van Hung Nguyen, et al.. (2023). Contributions of cost-effectiveness analyses (CEA) to influenza vaccination policy for older adults in Europe. Vaccine. 41(38). 5518–5524. 5 indexed citations
4.
Postma, Maarten J., A Chicoye, Nancy Devlin, et al.. (2022). Capturing the value of vaccination within health technology assessment and health economics: Country analysis and priority value concepts. Vaccine. 40(30). 3999–4007. 22 indexed citations
5.
Bugnon, Olivier, A Chicoye, S. Dejager, et al.. (2019). Impact of a Community Pharmacist-Delivered Information Program on the Follow-up of Type-2 Diabetic Patients: A Cluster Randomized Controlled Study. Advances in Therapy. 36(6). 1291–1303. 22 indexed citations
6.
Bugnon, Olivier, A Chicoye, Bruno Vergès, et al.. (2017). Impact of a Community Pharmacy-Based Information Program on Type 2 Diabetic Patients’ Adherence: Iphodia, a Cluster Randomized Study VS Usual Practice - 12 Month Final Results. Value in Health. 20(9). A483–A483. 1 indexed citations
7.
Bugnon, Olivier, A Chicoye, Bruno Vergès, et al.. (2016). Impact of a Community Pharmacy-Based Information Program on Type 2 Diabetic Patients’ Adherence to Their Oral Treatment: Iphodia, A Cluster Randomized Study Vs Usual Practice. Value in Health. 19(7). A675–A676. 1 indexed citations
8.
Chevalier, Julie, et al.. (2016). Cost-Effectiveness of Treatments for Relapsing Remitting Multiple Sclerosis: A French Societal Perspective. PLoS ONE. 11(3). e0150703–e0150703. 23 indexed citations
9.
Bousquet, Jean, P. Scheinmann, Françoise Neukirch, et al.. (2007). Pharmacoeconomic assessment of specific immunotherapy versus current symptomatic treatment for allergic rhinitis and asthma in France.. PubMed. 39(5). 148–56. 38 indexed citations
10.
Largeron, Nathalie, et al.. (2006). PGI8 COST-EFFECTIVENESS ANALYSIS OF ROTAVIRUS VACCINATION PROGRAMME IN THE UK. Value in Health. 9(6). A243–A244. 2 indexed citations
11.
Llorca, Pierre‐Michel, Christophe Lançon, F Casadebaig, et al.. (2005). Analyse coût-efficacité des stratégies de prise en charge des patients schizophrènes : place d’un antipsychotique atypique sous forme injectable à libération prolongée. L Encéphale. 31(2). 235–246. 37 indexed citations
12.
Chicoye, A, et al.. (2002). L'évaluation médico-économique de l'hémophilie à l'aube du troisième millénaire. Hématologie. 7(6). 445–452. 1 indexed citations
13.
Portier, H., D. Peyramond, I. Boucot, et al.. (2001). Évaluation pharmaco-économique de l'usage des tests de diagnostic rapide dans l'angine de l'adulte. Médecine et Maladies Infectieuses. 31(7-8). 506–507. 2 indexed citations
14.
Bousquet, Jean, Jalel Knani, H. Dhivert, et al.. (1994). Quality of Life in Asthma. I. Internal Consistency and Validity of the SF-36 Questionnaire. American Journal of Respiratory and Critical Care Medicine. 149(2). 371–375. 328 indexed citations
15.
Lebrun, T, et al.. (1994). [Functional and occupational repercussions and seeking care services in chronic asthma].. PubMed. 11(4). 369–78. 1 indexed citations
16.
Richard, A, P. Henry, G Chazot, et al.. (1993). [Quality of life and migraine. Validation of the QVM questionnaire in hospital consultation and in general medicine].. PubMed. 48(2). 89–96. 39 indexed citations
17.
Ambroise-Thomas, P, Bernard Uzzan, A Chicoye, & Florence Lacombe. (1988). French Context for Clinical Evaluation of Drugs: Network of Clinical Pharmacology and Good Clinical Practices. Drug Information Journal. 22(4). 581–586. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Peg Strub Breakdown of academic impact, for papers by K. Annunziata Breakdown of academic impact, for papers by F. S. Wamboldt Breakdown of academic impact, for papers by Tamara J. Musumeci‐Szabó Breakdown of academic impact, for papers by Caroline Stridsman Breakdown of academic impact, for papers by Dennis Thomas Breakdown of academic impact, for papers by Melina Rincon Breakdown of academic impact, for papers by Reinier P. Akkermans Breakdown of academic impact, for papers by K Trakas Breakdown of academic impact, for papers by Lisette van den Bemt
Rankless by CCL
2026